In a further evidence suggesting that rolling out programme against the Human Papilloma Virus (HPV) in India was incorrect, a recent study has said that current data on HPV and cervical cancer incidence in India does not support the claim of the promoters of the vaccine that India had a large burden of cervical cancer.

“Neither the epidemiological evidence nor the current cancer surveillance systems justify general rollout of a HPV vaccination programme either in India or in the two states where Path was conducting its research,” the study published in the journal of the Royal Society of Medicine cited.